Bristol-Myers Squibb Company
ANTIBODIES THAT BIND NOVEL PCSK9 VARIANTS
Last updated:
Abstract:
The present invention provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel PCSK9b and PCSK9c polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
Status:
Application
Type:
Utility
Filling date:
26 Feb 2019
Issue date:
9 Jan 2020